Controlled Release Drug Delivery Market Analysis - Global Industry Size, Share, Trends and Forecast 2022 - 2030

Name: Controlled Release Drug Delivery Market Analysis - Global Industry Size, Share, Trends and Forecast 2022 - 2030
Creator: Acumen Research and Consulting
Published: Jul 2022
License: https://www.acumenresearchandconsulting.com/privacy-policy

Published : Jul 2022

Report ID: ARC981

Pages : 160

Format : Controlled Release Drug Delivery Market Analysis - Global Industry Size, Share, Trends and Forecast 2022 - 2030

Summary Table of Content Customization Download Sample Infographics

The global controlled release drug delivery market size projected to register around USD 91.2 billion by 2026, this market is anticipated to grow with 14.3% CAGR during the forecast time period. The market is driven by increasing technology spending in healthcare sector.

Market Dynamics

Soaring demand for pediatric and geriatric controlled release delivery methods and substitute therapies and increasing consciousness about advantages of these systems over conventional forms are providing a fillip to the controlled release drug delivery market market.

These technologies deliver numerous advantages over old-style delivery forms. Uniform drug effect, reduced dosage and less gastrointestinal side effects, dosage frequency, enhanced patient compliance, improved drug efficacy & safety, and reduced fluctuation of plasma drug levels are some of the advantages delivered by these technologies.

Market Insights

Controlled release drug delivery systems permit reduction in quantity of dose and dose frequency, increased patient compliance and acceptance, less fluctuation in plasma drug levels, uniform drug result, and improved effectualness quantitative relation of administered therapeutic. as compared to traditional delivery, these systems accomplish a chronic therapeutic result, increase foregone conclusion in drug unleash dynamics, and produce concerning delivery at a pre-determined rate regionally or consistently. Thus, with many more blessings offered by these systems, their adoption is slated to extend at a motivating rate over the approaching years.

Market Segmentation

Market By Release Mechanism

Polymer Based Systems
Micro Reservoir Partition Controlled Drug Delivery Systems
Feedback Regulated Drug Delivery Systems
Activation-modulated Drug Delivery Systems
- Osmotic Pressure Activated
- Hydrodynamic Pressure Activated
- Vapor Pressure Activated
- Mechanically Activated
- Magnetically Activated
Chemically Activated
- pH Activated
- Hydrolysis Activated
- Enzyme Activated

Market By Technology

Wurster Technique
Coacervation
Micro Encapsulation
Implants
Transdermal
Targeted Delivery
Others

Market By Application

Metered Dose Inhalers
Injectable
Transdermal and Ocular Patches
Infusion Pumps
Oral Controlled-drug delivery Systems
Drug Eluting Stents

Market By Geography

North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- Rest of Asia-Pacific
Latin America
- Brazil
- Chile
- Rest of Latin America
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- Rest of MEA

Regional Insights

North America captures the largest revenue share at 35.6% and will continue to retain its dominance position over the forthcoming years. Speedy acceptance of advanced devices and technologies and high per capita healthcare expenditure are expected to surge the need for connected drug delivery systems in the region. High price of controlled release drug delivery is expected to be the one of the substantial factor in hampering the market growth in emerging regions such as MEA, APAC and Latin America. Though, with the growing numeral of market entrants the device prices are anticipated to fall over time; this will backing the market growth in emerging such countries such as India and China.

Market Participants

The major players associated with the controlled release drug delivery market Capsugel, Orbis Biosciences, Inc., Pfizer, Inc, Merck and Co., Inc., Johnson and Johnson, Alkermes plc, Coating Place, Inc., Depomed, Inc., Corium International, Inc., and Aradigm Corporation. Most of these firms put stress on new product launch and mergers & acquisitions, technological expansion, and strategic partnership activities as part of their commercial growth strategies.